This stock no longer trades (delisted June 28, 2022)

Delisted / no longer publicly traded (per market data provider) Everything below is based on the last available data — treat it as historical, not a live read.

Stock

Elevance Health

ANTM
58
Medical - Healthcare Plans · Healthcare
Price
$482.58
+12.71 (+2.71%)
Market Cap
$114.59B
Exchange
New York Stock Exchange
Winston Score
58
Historical score — this stock no longer trades, so the score is frozen at the last available data.
Data as of Oct 18, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Exceptional
30/30
Growth
Weak
3/20
Cash Flow
Strong
7/10
Stability
Exceptional
10/10
Valuation
Good
6/10
Ownership
Weak
1/15
Dividends
Weak
1/5

58 of 100 counted points = Winston Score 58.

Share count falling — buybacks

−6.5% over 6y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 260.3M (2019) → 243.4M (2025)

§Winston Score History

The full picture

Elevance Health, formerly known as Anthem, is one of the largest health insurance companies in the United States. It provides medical, dental, vision, and pharmacy benefit plans to individuals, employers, and government programs like Medicaid and Medicare. The company operates Blue Cross and Blue Shield plans in 14 states, making it the largest managed care company by medical membership associated with that well-known brand.

Elevance makes money primarily through insurance premiums collected from members and their employers, along with fees for administering health plans. It serves over 45 million members across the U.S. and generates over $170 billion in annual revenue. Its large membership base gives it strong negotiating power with hospitals and doctors, which helps keep costs competitive. Key growth opportunities include expanding its Carelon health services segment, which provides pharmacy, behavioral health, and care delivery services, though rising medical costs and regulatory changes in government health programs remain ongoing risks.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
89.1%
Premium pricing power — 89.1% gross margin
Profit after running costs
Operating Margin
78.1%
Excellent — 78.1% operating margin
Return on the money invested
ROCE
346.2%
Exceptional — 346.2% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
N/A
Data not available
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
151%
Turns 151% of profit into real cash
Spare cash per sale
FCF Margin
3.1%
Thin free cash flow (3.1%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.01
Conservative — low debt load (0.01)
Covers its interest
Interest Cover
108.97x
Comfortably covers interest (109.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
2.1x
Attractive valuation — P/E 2.1

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
1.43%
Small dividend — 1.43% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+1.6%
Dividend flat
Payout Ratio
29%
no trend
Pays out a modest share of profit and keeps the rest to reinvest. Room to keep paying through a weak year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial